Promega Lunch & Learn: Drug the Undruggable, in Living Cells

Join us for an insightful session on From Hits to Mechanism: Target Engagement, Ternary Complex, and BRETSA in Live Cells! Promega will showcase advanced applications of the NanoLuc® luciferase platform to dissect compound mechanisms of action in living cells. Learn about:

• NanoBRET® target engagement
• NanoBiT and NanoBRET® methods for ternary complex formation
• HiBiT-based degradation kinetics

Discover the innovative TarSeer BRETSA, a new tool for assessing druggability that targets often overlooked 'dark' and intrinsically disordered targets. Bring your toughest assay-development questions!

🍽️ Lunch will be provided!

Meet Our Experts:

• Andrew Zhang: Strategic Collaborations Manager at Promega, with over 10 years in drug discovery and former Head of Chemical Biology at AstraZeneca.
• Megan Luedeman: Upstream Product Manager at Promega, specializing in NanoLuc and HiBiT technologies. She's eager to discuss your experiences with live-cell assays.
• Victoria Echeverria: Account Manager at Promega with 20 years in the industry, passionate about supporting biotech startups and connecting them with essential tools.

📍 Location: 135 Mississippi St
🔗 Register Here!